Phase 2 OCD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been officially diagnosed with OCD (Obsessive-Compulsive Disorder) by a trained mental health professional.
- Your OCD symptoms score 16 or higher on a standard OCD rating scale (called the Y-BOCS), indicating significant symptoms.
- Your OCD has not improved enough after trying at least one standard medication or therapy treatment.
- You are between 18 and 65 years old.
- You have stopped taking certain antidepressants (SSRIs) for a specific washout period before joining (confirm exact timing with trial site).
- You agree not to start any new therapy or psychiatric medication during the study without checking with the study team first.
- You are willing to avoid all psychiatric medications and recreational drugs throughout the study.
- If you could become pregnant, you have a negative pregnancy test at the start and before each study session, and you agree to use reliable contraception.
- You are willing to allow the researchers to speak with your doctors or therapist to verify your medical and medication history if needed.
- You can provide a contact person (such as a family member or close friend) who can be reached by the research team in an emergency.
- You are committed to attending all medication sessions, therapy sessions, and follow-up appointments for the full study.
Who may not be able to join:
- You or a close family member have a history of schizophrenia, bipolar disorder, delusional disorder, paranoid disorder, or schizoaffective disorder.
- You have had a substance abuse problem in the past 12 months.
- You have an unstable neurological or medical condition.
- You currently have thoughts of suicide or have attempted suicide in the past 12 months.
- You have a history of violence, self-harm, or harming others.
- You have any unstable health condition that could make the study procedures unsafe.
- You have a positive pregnancy test at the time of screening.
- You have used any psychedelic drugs in the past 12 months.
- You are not able to understand and sign a consent form agreeing to take part.
- You experience an unexpected or unusual reaction to any part of the study while it is ongoing.
- You decide you would like to stop participating once the study has begun.
- You have a positive pregnancy test at any point before the final psychedelic session.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Oded Arbel, MD, Beersheva Mental Health Center
Phone: +972506576691
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS ) change from baseline; Obsessive-Compulsive Inventory-Revised (OCI-R) change from baseline; Obsessional Beliefs Questionnaire (OBQ-20) change from baseline; Beck Depression Inventory -II (BDI-II) change from baseline; Beck Anxiety Inventory (BAI) change from baseline; Mini International Neuropsychiatric Interview (M.I.N.I.) change from baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.